METTL3-driven IFIT2 mRNA degradation in a YTHDF2-dependent fashion is demonstrated to facilitate ICC progression (Xu Q. C. et al., 2022). This evidence concerns the gene METTL3 and intrahepatic cholangiocarcinoma.